Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Vaccibody: Promising Preclinical Data With COVID-19 Vaccine Candidate In Mice

Dec 10 (Reuters) - Vaccibody AS  VACC-ME.OL :
    * REPORTS PROMISING PRECLINICAL DATA WITH A
SECOND-GENERATION
COVID-19 VACCINE AND ANNOUNCES ITS INFECTIOUS DISEASE STRATEGY
    * PROMISING PRE-CLINICAL DATA WITH ITS COVID-19 VACCINE
CANDIDATE,
VB10.COV2, IN MICE

Source text for Eikon:  ID:nObiymPzTa 
Further company coverage:  VACC-ME.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))

Recent news on Nykode Therapeutics ASA

See all news